Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Chemoprevention in Premenopausal Women at Increased Risk for Breast Cancer
NCT01905046Phase 3Active, not recruiting
- Sponsor
- Cancer and Leukemia Group B
- Start
- Nov 2015
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in breast cancer, sponsored by Cancer and Leukemia Group B. Started Nov 2015; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01905046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01905046.